NEJM Interviews NEJM Interview: Dr. Joseph Ross on shifts in the FDA’s use of accelerated approval and associated challenges for clinicians and patients.
Apr 5, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
The FDA Approval of a Monoclonal Antibody for Treating Alzheimer's Disease
02:26 • 3min
The Challenges of Accelerated Approval for Cancer Treatment
05:33 • 3min
The Future of Accelerated Approval
08:33 • 2min
The Importance of Patient Education in FDA Approval
10:17 • 2min